Cookie Settings
This site uses cookies to store information on your computer, to improve your experience. One of the cookies this site uses is essential for parts of the site to operate and has already been set. You may delete and block all cookies from this site, but parts of the site will not work. To find out more about the cookies this site uses and how to delete them, please see the privacy notice.
skip to main content
Southern Health NHS Foundation Trust Southern Health Covid-19 Service Changes
Site search
Home > Services > Research > Research and Development > Previous Studies > TRD QoL

TRD QoL

TRD QoL

This study looks at the quality of life of those living with depression currently not responding to medication, newly diagnosed patients and carers (self-identified, could be family or friend) of those with depression.

If you would like to take part you will be asked to complete a short questionnaire that asks about your mood and quality of life. This will take approximately 25 minutes and you will receive a £15 love2shop voucher. There is a second part of the study that you may be asked to take part in which is an interview. This is longer and conducted by the sponsor (Janssen Cilag), for this you will receive two £15 love2shop vouchers.

To take part you must meet the following criteria:

 

Patients

 

(1)  Major Depressive Disorder

  • First oral antidepressant under 8wks
  • Symptomatic

 

(2)  Treatment Resistant Depression

  • Two or more anti-depressant changes. Needs to be on the anti-depressant for 8 weeks or more before changing. 
  • Symptomatic

 

(3)  Treatment Resistant Depression in Remission

  • Third or later oral antidepressant & treatment responsive
  • In remission for minimum of 4 weeks

 

Carers

(4)  TRD 

  • Carer of patient with symptomatic TRD

 

(5)  TRD-R

  • Carer of patient with TRD in remission

 

NOTE: If you only want to take part in the questionnaire you can choose not to participate in the interview stage.

If you would like to take part or want more information please contact the study lead:

Study Contact: Marek Czeldadzki

Email: Marek.Czeladzki@southernhealth.nhs.uk

Tel: 02380 475943

Other studies

Page Comments